Search Results - Delozier, T.

Phase III study of bevacizumab plus docetaxel compared with placebo plus docetaxel for the first-line treatment of human epidermal growth factor receptor 2-negative metastatic brea... by Miles, D., Chan, Arlene, Dirix, L., Cortés, J., Pivot, X., Tomczak, P., Delozier, T., Sohn, J., Provencher, L., Puglisi, F., Harbeck, N., Steger, G., Schneeweiss, A., Wardley, A., Chlistalla, A., Romieu, G.

Get full text

Report from the fifth international consensus meeting to harmonize core outcome measures for atopic eczema/dermatitis clinical trials (HOME initiative) by Chalmers, J.R., Thomas, K.S., Apfelbacher, C., Williams, H.C., Prinsen, C.A., Spuls, P.I., Simpson, E., Gerbens, L.A.A., Boers, M., Barbarot, S., Stalder, J.F., Abuabara, K., Aoki, V., Ardeleanu, M., Armstrong, J., Bang, B., Berents, T.L., Burton, T., Butler, L., Chubachi, T., Cresswell-Melville, A., DeLozier, A., Eckert, L., Eichenfield, L., Flohr, C., Futamura, M., Gadkari, A., Gjerde, E.S., van Halewijn, K.F., Hawkes, C., Howells, L., Howie, L., Humphreys, R., Ishii, H.A., Kataoka, Y., Katayama, I., Kouwenhoven, W., Langan, S.M., Leshem, Y.A., Merhand, S., Mina-Osorio, P., Murota, H., Nakahara, T., Nunes, F.P., Nygaard, U., Nygårdas, M., Ohya, Y., Ono, E., Rehbinder, E., Rogers, N.K., Romeijn, G.L.E., Schuttelaar, M.L.A., Sears, A.V., Simpson, M.A., Singh, J.A., Srour, J., Stuart, B., Svensson, Å., Talmo, G., Talmo, H., Teixeira, H.D., Thyssen, J.P., Todd, G., Torchet, F., Volke, A., von Kobyletzki, L., Weisshaar, E., Wollenberg, A., Zaniboni, M.

Get full text